In 2015, the team competed as a club, before returning to Continental status the following year.

From 2017 until its disbanding in 2019 the team held Professional Continental status.

[2] In April 2019 the team terminated Wilmar Paredes’ contract after the UCI announced that he had tested positive for EPO.

[3] In May 2019 Juan José Amador notified of an adverse analytical finding for the banned steroid, Boldenone an out-of-competition control held on 22 October 2018.

According to UCI anti-doping regulation 7.12.1, the team will now be suspended for a period of between 15 and 45 days, to be decided by the UCI Disciplinary Commission, due to the team registering a second adverse analytical finding within a 12-month period.